Spironolactone for Hormonal Acne
Spironolactone is one of the most commonly prescribed options for persistent adult hormonal acne, particularly the jawline-and-chin pattern that doesn’t respond well to standard topical treatment. Here’s how it actually works, and what a realistic timeline looks like — this is educational information, not a substitute for a conversation with your prescriber.
What it is and how it works
Spironolactone is an oral prescription medicine with antiandrogen effects. In the U.S., acne treatment is an off-label use: the 2024 acne guideline conditionally recommends it, while the ALDACTONE label lists other indications. A jawline pattern alone does not establish a hormonal disorder.
Realistic timeline
Trial outcomes at 12 and 24 weeks: SAFA randomized trial (PubMed).
In the SAFA randomized trial, 410 adult women were assigned spironolactone or placebo and could continue topical treatment. Self-reported improvement at 12 weeks was 72% versus 68%, without a statistically significant difference; at 24 weeks it was 82% versus 63%. Benefit was greater at 24 weeks than at 12 weeks.
These results are not an 80% response rate at 6–12 weeks or a promise of complete clearing. Your prescriber sets the dose, follow-up and treatment duration according to response and tolerability.
What to expect, side-effect-wise
Safety, pregnancy and individualized potassium monitoring: U.S. ALDACTONE prescribing information; Potassium monitoring in healthy young women (PubMed); Age and hyperkalemia study (PubMed); AAD hormonal acne guidance.
Possible effects include increased urination, dizziness, breast tenderness and menstrual changes. Headaches were more frequent with spironolactone in SAFA. High potassium and impaired kidney function are important safety concerns.
Potassium testing is individualized. A study in healthy young women found routine monitoring had low usefulness; a small retrospective study found higher risk in women over 45. These findings do not apply to everyone. Kidney disease, age and medicines or supplements that raise potassium change the assessment. The U.S. prescribing label advises early and regular potassium monitoring for its labeled uses. Ask your acne prescriber whether baseline kidney function and potassium tests, and subsequent tests, are needed.
Avoid spironolactone during pregnancy because of potential effects on fetal sex development. Discuss pregnancy plans and effective contraception before treatment; spironolactone itself is not contraception. Tell your prescriber about all medicines, potassium supplements and salt substitutes.
How it fits with the rest of your routine
Topical acne treatments may remain part of the plan. Choose them with your prescriber and adjust if irritation develops; reduced oiliness does not establish that retinoids will become easier to tolerate. See our non-prescription acne routine.
If PCOS is part of your picture, spironolactone is frequently used as one part of a broader treatment plan — see our PCOS Acne Treatment guide for the fuller picture.
Is it right for you?
Conditional acne-guideline recommendation: 2024 acne guideline (PubMed).
This is a conversation for your prescriber, not something to self-start or self-adjust. It tends to be considered for adult women with persistent, hormonally-patterned acne — particularly jawline/chin concentrated, cystic, or cycle-linked — who haven’t had enough improvement from topical treatment alone. See our overview of that pattern in Hormonal Acne vs. Regular Acne.
FAQ
Is spironolactone the same as birth control for acne?
No — they work differently and are sometimes used together. Birth control regulates hormone levels more broadly; spironolactone blocks androgen effects directly at the skin and hair follicle level. See Birth Control and Acne for how that option works.
Do I need regular blood tests while taking it?
There is no single blood-test schedule for every acne patient. Follow the monitoring plan your prescriber sets after considering kidney function, age, health conditions and interacting medicines.
What happens if I stop taking it?
Acne can return, since spironolactone treats the hormonal driver rather than curing the underlying tendency. This is a conversation to have with your prescriber if you’re considering stopping.
References
- Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial BMJ · 2023
- ALDACTONE (spironolactone) — U.S. prescribing information Pfizer · 2025
- Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne JAMA Dermatology · 2015
- Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program International Journal of Women’s Dermatology · 2019
- Stubborn acne? Hormonal therapy may help American Academy of Dermatology
- Guidelines of care for the management of acne vulgaris Journal of the American Academy of Dermatology · 2024
Dermlore provides general educational information, not personal medical advice, diagnosis or treatment. Reading this site does not create a doctor–patient relationship. Consult a qualified healthcare professional for advice about your circumstances. Medical disclaimer.